Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730728 · ClinicalTrials.gov registry record · NA
Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA
A NA study of Osteoarthritis and Total Knee Arthroplasty, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
- 1
- Study location
NCT02730728: Completed NA study of Osteoarthritis and Total Knee Arthroplasty, sponsored by University of Pennsylvania.
NCT02730728 is a NA study of Osteoarthritis and Total Knee Arthroplasty that has completed, run by University of Pennsylvania. The registered enrollment target is 159 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02730728, a NA study of Osteoarthritis and Total Knee Arthroplasty, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare a single shot block, 24 hours, and 48 hour continuous catheter nerve block done via the adductor canal method in adult patients who have under gone total knee arthroplasty. Visual analogue scores, opioid consumption, time to up and go, ambulation, manual muscle tests, and Tinetti scores up to 72 hours post operatively will be used for comparison.
Primary Outcome
The proportion of patients reporting severe pain, defined as pain score (7-10) through the second postoperative day
Conditions Studied
Interventions
- DRUG 20ml bolus of 0.5% ropivicaine
- DRUG 0.2% Ropivicaine at 8 milliliter/hour
- DRUG 5ml bolus of 0.5% ropivicaine
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2015-11-01 |
| Est. Completion | 2017-01-01 |
| Phase | NA |
What the finished NCT02730728 record still lists
NCT02730728 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which 20ml bolus of 0.5% ropivicaine is the first listed.
NCT02730728 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02730728 about?
NCT02730728 is a clinical study titled "Single Shot vs 24hr vs 48hr Continuous Adductor Canal Block After TKA". The purpose of this study is to compare a single shot block, 24 hours, and 48 hour continuous catheter nerve block done via the adductor canal method in adult patients who have under gone total knee arthroplasty. Visual analogue scores, opioid consumption, time to up and go, ambulation, manual muscl...
What is the current status of trial NCT02730728?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2015-11-01. Estimated completion is 2017-01-01.
What conditions does trial NCT02730728 study?
This clinical trial studies the following conditions: Osteoarthritis, Total Knee Arthroplasty, Postoperative Pain Control.
What interventions are being tested in trial NCT02730728?
The interventions under investigation include: 20ml bolus of 0.5% ropivicaine (DRUG), 0.2% Ropivicaine at 8 milliliter/hour (DRUG), 5ml bolus of 0.5% ropivicaine (DRUG).
Who is sponsoring clinical trial NCT02730728?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02730728 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02730728's enrollment target sits among peer trials
159 70th of 135 higher than 66 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy
RECRUITING · NA
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
RECRUITING · NA
-
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI